ampicillin/ampicillin trihydrate · Bristol · NDA 050093, 050308, 050310
Polycillin
Earliest generic entry, as listed · earliest of 7 marketed strengths
Open now
No marketed reference-listed strength; date taken from all listed strengths.
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 7
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 050093 · 001 · discontinued | tablet, chewable, oral | EQ 125MG BASE | open |
| 050308 · 001 · discontinued | for suspension, oral | EQ 125MG BASE/5ML | open |
| 050308 · 002 · discontinued | for suspension, oral | EQ 250MG BASE/5ML | open |
| 050308 · 003 · discontinued | for suspension, oral | EQ 500MG BASE/5ML | open |
| 050308 · 004 · discontinued | for suspension, oral | EQ 100MG BASE/ML | open |
| 050310 · 001 · discontinued | capsule, oral | EQ 250MG BASE | open |
| 050310 · 002 · discontinued | capsule, oral | EQ 500MG BASE | open |